Related content

Rituximab for chronic lymphocytic leukemia

By Robak Tadeusz  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 4, 2012-04 ,pp. : 503-515

Informa Healthcare

Access to resources Recommend Favorite

MicroRNAs as Main Players in the Pathogenesis of Chronic Lymphocytic Leukemia

By  

MicroRNA, Vol. 2, Iss. 3, 2013-11 ,pp. : 158-164

Bentham Science Publishers

Access to resources Recommend Favorite

Ofatumumab, a human anti-CD20 monoclonal antibody

By Österborg Anders  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 3, 2010-03 ,pp. : 439-449

Informa Healthcare

Access to resources Recommend Favorite

Chemokine-dependent B cell–T cell interactions in chronic lymphocytic leukemia and multiple myeloma – targets for therapeutic intervention?

By Jöhrer Karin   Hofbauer Sebastian W   Zelle-Rieser Claudia   Greil Richard   Hartmann Tanja N  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 4, 2012-04 ,pp. : 425-441

Informa Healthcare

Access to resources Recommend Favorite

Imbalanced Expression of the Glucocorticoid Receptor Isoforms in Cultured Lymphocytes from a Patient with Systemic Glucocorticoid Resistance and Chronic Lymphocytic Leukemia

By Shahidi H.   Vottero A.   Stratakis C.A.   Taymans S.E.   Karl M.   Longui C.A.   Chrousos G.P.   Daughaday W.H.   Gregory S.A.   Plate J.M.D.  

Biochemical and Biophysical Research Communications, Vol. 254, Iss. 3, 1999-01 ,pp. : 559-565

Elsevier

Access to resources Recommend Favorite